Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

NRG announces £16m Series A for IND for Parkinson’s and ALS

9 November 2022

PharmaPhorum

https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/scan_pic.jpg 400 605 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2022-11-09 08:05:142026-08-14 16:03:58NRG announces £16m Series A for IND for Parkinson’s and ALS

Terms & Conditions
Privacy Policy

Following the path to a new drug, together

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and...

Scroll to top